In some studies, CA125 was regularly detected after surgery and chemotherapy in 225 patients with advanced ovarian cancer, and the complete remission rate of patients with serum CA125 half-life <25 d was found to be 3.6 times higher than that of patients with >25 d through analysis combined with the results of secondary exploration 15. The gene discussed is MUC16; the disease is ovarian cancer.